Cargando…
Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria
Primary hyperoxalurias (PHs) are autosomal recessive disorders caused by the overproduction of oxalate leading to calcium oxalate precipitation in the kidney and eventually to end-stage renal disease. One promising strategy to treat PHs is to reduce the hepatic production of oxalate through substrat...
Autores principales: | Lai, Chengjung, Pursell, Natalie, Gierut, Jessica, Saxena, Utsav, Zhou, Wei, Dills, Michael, Diwanji, Rohan, Dutta, Chaitali, Koser, Martin, Nazef, Naim, Storr, Rachel, Kim, Boyoung, Martin-Higueras, Cristina, Salido, Eduardo, Wang, Weimin, Abrams, Marc, Dudek, Henryk, Brown, Bob D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094358/ https://www.ncbi.nlm.nih.gov/pubmed/29914758 http://dx.doi.org/10.1016/j.ymthe.2018.05.016 |
Ejemplares similares
-
Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1
por: Dutta, Chaitali, et al.
Publicado: (2016) -
Inhibition of Glycogen Synthase II with RNAi Prevents Liver Injury in Mouse Models of Glycogen Storage Diseases
por: Pursell, Natalie, et al.
Publicado: (2018) -
Therapeutic RNA interference: A novel approach to the treatment of primary hyperoxaluria
por: Forbes, Thomas A., et al.
Publicado: (2021) -
Chronic liver disease and hepatic calcium-oxalate deposition in patients with primary hyperoxaluria type I
por: Recker, Pia, et al.
Publicado: (2022) -
In vivo oxalate degradation by liposome encapsulated oxalate oxidase in rat model of hyperoxaluria
por: Dahiya, Tulika, et al.
Publicado: (2013)